Zobrazeno 1 - 10
of 1 325
pro vyhledávání: '"Federlin, K"'
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 107:332-335
In 20 type I diabetics comparison were made between Optisulin -depot CS (25% dissolved porcine Des-Phe-insulin/insulin and 75% crystalline porcine insulin), an intermediary insulin without depot additives, and two depot-additive containing insulins (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::501215692c8d52bec38ce6b8a80bec8c
https://doi.org/10.1055/s-2008-1069928
https://doi.org/10.1055/s-2008-1069928
Autor:
Federlin K
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 105:233-237
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52da029f3d0a5a0c2009f8e438531504
https://doi.org/10.1055/s-2008-1070641
https://doi.org/10.1055/s-2008-1070641
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 111:369-373
Cytoplasmic islet-cell antibodies, insulin antibodies, islet-cell surface antibodies and islet-cell specific cytotoxicity were determined in serum of the following groups: 131 patients with type I diabetes, 19 with type II diabetes, 29 with mumps, 29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e6ad9f697aa561e35a38e1427da059f
https://doi.org/10.1055/s-2008-1068457
https://doi.org/10.1055/s-2008-1068457
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 110:403-406
During in-patient admission after metabolic stabilisation insulin treatment of 32 type-1-diabetics was changed from bovine insulin (Depot-Insulin Hoechst CR) to semisynthetic human insulin of the intermediary type (Depot-H-Insulin Hoechst). Out-patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9040dcae247aa8601356d6a7b39b4882
https://doi.org/10.1055/s-2008-1068835
https://doi.org/10.1055/s-2008-1068835
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 109:419-421
Among 16 type II diabetics who were secondary failures on sulphonylurea treatment alone, eight (group A) were changed to a combined regimen of insulin and sulphonylurea (glibenclamide), the other eight (group B) received insulin alone. Patients in gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed44fe2f974b2696dfae0dd81186866c
https://doi.org/10.1055/s-2008-1069205
https://doi.org/10.1055/s-2008-1069205
Autor:
Federlin K
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 112:1704-1706
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32d2a5f633f6de28c2e800b47d2de5bb
https://doi.org/10.1055/s-2008-1068317
https://doi.org/10.1055/s-2008-1068317